Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01557790 · ClinicalTrials.gov registry record · NA
Proton Radiotherapy for Stage I, IIA, and IIB Seminoma
A NA study, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT01557790: Completed NA study, sponsored by Abramson Cancer Center at Penn Medicine.
NCT01557790 is a NA study that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01557790, a NA study, has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
Phase II study using Proton radiation therapy to treat males, aged 18 years or older, with Stage I, IIA and IIB Seminoma. This research study will be done in conjunction with the Robert H. Burr Proton Therapy Center at the Mass. General Hospital and the Department of Defense. In the feasibility portion of the study patients will be evaluated to determine acute toxicity. If the study is deemed feasible the principal investigator (PI) hopes that proton RT will reduce the lethargy rate as compared to photon radiation therapy (RT).
Interventions
- RADIATION Proton Radiation Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2012-03 |
| Est. Completion | 2017-12 |
| Phase | NA |
What the finished NCT01557790 record still lists
NCT01557790 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Proton Radiation Therapy is the first listed.
NCT01557790 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01557790 about?
NCT01557790 is a clinical study titled "Proton Radiotherapy for Stage I, IIA, and IIB Seminoma". Phase II study using Proton radiation therapy to treat males, aged 18 years or older, with Stage I, IIA and IIB Seminoma. This research study will be done in conjunction with the Robert H. Burr Proton Therapy Center at the Mass. General Hospital and the Department of Defense. In the feasibility port...
What is the current status of trial NCT01557790?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2012-03. Estimated completion is 2017-12.
What interventions are being tested in trial NCT01557790?
The interventions under investigation include: Proton Radiation Therapy (RADIATION).
Who is sponsoring clinical trial NCT01557790?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01557790's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia